1 result for "Foundation Medicine, Inc."
Add this URL to any RSS reader. Updated daily.
Genentech, Foundation Medicine Patent EP3523451A1, Cancer Treatment Methods
European patent application EP3523451A1 published April 15, 2026, listing Genentech, Inc. and Foundation Medicine, Inc. as joint applicants for therapeutic and diagnostic methods in cancer (A61P 35/00). Nine named inventors are credited across immuno-oncology and companion diagnostics. IPC classifications include C12Q, A61K, A61P, and C07K 16/28.
Routine
Rule
Intellectual Property
Get alerts for "Foundation Medicine, Inc."
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
74
AI Regulation
3
Banking & Finance
432
Consumer Protection
94
Courts & Legal
420
Data Privacy & Cybersecurity
92
Defense & National Security
53
Education
60
Energy
101
Environment
162
Gaming
2
Government & Legislation
440
Healthcare
15
Healthcare & Life Sciences
387
Immigration
10
Insurance
80
Labor & Employment
148
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
83
Securities & Markets
159
Tax
83
Telecom & Technology
48
Trade & Sanctions
141
Transportation
93
Get alerts for "Foundation Medicine, Inc."
We'll email you when new changes match "Foundation Medicine, Inc.".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!